Original Contributions |
| Abstract |
|---|
|
|
|---|
G and
E) between them, and the additive
genetic variance of each subfraction's response to the diets. On the
Chow diet, genetic correlations between the 3 subfractions were
significant, and we observed complete pleiotropy between
HDL1-C and HDL3-C (
G=-0.81). On
the HCSF diet, only the genetic correlation between HDL1-C
and HDL3-C (
G=-0.61) was significant.
Genetic correlations between individual subfractions on the Chow and
HCSF diets did not differ significantly from 1.0, indicating that the
same additive genes influenced each subfraction's levels regardless of
diet. However, the additive genetic variance of response to the diets
was highly significant for HDL1-C and HDL2-C,
but not for HDL3-C. Similar sets of genes influence
variation in the 3 HDL subfractions on the Chow diet, and the same set
influences variation in each subfraction on the HCSF diet. However, the
expression of genes influencing HDL1-C and
HDL2-C is altered by the HCSF diet, disrupting the
pleiotropy observed between the 3 subfractions on the Chow diet.
Key Words: atherosclerosis risk factors lipemic response dietary challenge animal models statistical genetics gradient gel electrophoresis
| Introduction |
|---|
|
|
|---|
Associations between HDL-C subfractions and other CVD risk factors also have been reported.12 13 Reduced HDL2-C levels are correlated with a predominance of large LDL particles and increased CVD risk14 and with increased fibrinogen levels in nonsmokers without CVD or infection.15 Hypertriglyceridemia, hyperinsulinemia, and high hepatic lipase activity are reported to be associated independently with decreased HDL2b-C levels in men with or without coronary artery disease and noninsulin-dependent diabetes mellitus.16
Several studies report associations of circulating levels of HDL-C and its subfractions with dietary intake of fat or cholesterol in humans. One study of 28 healthy subjects reports a negative correlation between the magnitude of postprandial triglyceridemic response to a standard oral fat meal and both total HDL-C and HDL2-C.17 Increased total HDL-C and HDL2-C levels are reported in response to postprandial lipemia in both carriers and controls in a study of the effects of the apolipoprotein apoA1Milano polymorphism.18 In 56 normocholesterolemic and hypercholesterolemic subjects, Clifton et al19 observed increases in total HDL-C levels and, in a high-response subgroup, a 10% increase in the proportion of HDL2-C to total HDL-C in response to a high cholesterol dietary challenge. Katan and Beynen20 reported a positive correlation between responsiveness to dietary cholesterol and serum HDL2-C levels whereas Fisher et al21 observed the opposite relationship.
HDL-C and its subfractions respond to variation in fat and cholesterol in the diet, but only a limited number of studies have addressed the genetics of this response. Although a study of monozygotic twins22 reports a significant intrapair resemblance in HDL-C response to a 22-day overfeeding challenge, nearly all other published studies focusing on HDL-C report attempts to detect associations between variation in lipemic response and mutations in specific candidate genes. Mata et al23 observed no differences in HDL-C levels when individuals of different apoA4 genotypes are challenged with high fat, high cholesterol diets. However, one study reports that the apoE 4/3 genotype is associated with a greater response of HDL-C to a high fat, high cholesterol diet than other apoE genotypes.24
There is substantial interspecies variability in responsiveness to dietary lipids and cholesterol.25 As is the case for studies of human subjects, nonhuman animal research has focused predominantly on the ß-lipoproteins and pre-ß-lipoproteins and associated components, ie, LDL-C, VLDL-C, apoB, apoE, and triglycerides, some of which have been posited as major factors in cholesterol transport.25 Only a limited number of groups have investigated the genetics of diet-induced changes in circulating HDL-C levels. In a laboratory marsupial (Monodelphis domestica), Rainwater and VandeBerg26 observed increased HDL-C levels in response to a cholesterol- and fat-enriched diet in animals that could be classified as both high and low responders on the basis of their VLDL+LDL-C responses to that same diet. In inbred mice the Ath-1 locus influences HDL-C response to dietary challenge and also influences atherogenesis in the aortic arch.27 Although these results suggest important insights into likely genetic influences on lipemic response in the studied species, salient differences in lipoprotein metabolism of these animal models may temper direct extrapolation to humans.
Their genetic proximity and metabolic similarities to humans increase the likelihood that studies using Old World monkeys to investigate genetic influences on lipoprotein metabolism and lipemic response will offer insights relevant to human physiology. Responses to dietary challenges have been reported for a number of nonhuman primate species, but those of baboons have proven to be more similar to humans in terms of cholesterol, lipoprotein, and lipid metabolism than those of other related species such as rhesus (Macaca mulatta), cynomolgus (Macaca fasicularis), or African green monkeys (Cercopithecus aethiops).25 28 McGill et al29 reported variable responses (from none to a 5-fold change) in both VLDL-C and HDL-C in 555 captive baboons (Papio hamadryas) challenged with a high fat, high cholesterol diet for 7 weeks. The HDL-C levels of the juvenile baboons, offspring of selectively bred high- and low-responding parents, were observed to diverge from birth through 2 years of age while they were fed identical diets.30 31 Although affecting HDL-C levels in these baboons, neither an unidentified major locus nor the LCAT structural locus exerted an effect on lipemic response32 33 ; however, another major locus for apoA1 was found to account for 33% of the variance in apoA1 response to diet.34
Studies in humans and nonhuman animals alike strongly support the notion that genes influence lipemic response of HDL-C or its subfractions. However the presence, nature, and extent of interactions between genes influencing quantitative variation in the concentrations of HDL-C subfractions and the amount of dietary cholesterol and fat have not been resolved. We have conducted a statistical genetic analysis in a baboon model for lipoprotein metabolism and atherosclerosis with the following objectives: (1) to detect and quantify the additive effects of genes on normal variation in serum levels of HDL1-C, HDL2-C, and HDL3-C in 2 dietary environmentsa low cholesterol, low fat diet and a high cholesterol, high fat diet; (2) to detect and characterize pleiotropic interactions among the additive polygenes influencing normal variation in serum levels of HDL1-C, HDL2-C, and HDL3-C in each of the 2 dietary environments; and (3) to evaluate evidence for interaction between HDL-C subfraction genotype and diet.
| Methods |
|---|
|
|
|---|
)
for these relative pairs were calculated by means of the Stevens-Boyce
algorithm.37 Within these pedigrees there were 2015
relative pairs with
=0.25 (first-degree relatives), 21 with
=0.1875, 83 with
=0.15625, 10 142 with
=0.1250, 1955 with
=0.0625, and 33 with
=0.03125. Baboons were maintained on a monkey chow diet low in cholesterol (0.03 mg/kcal) and fat (4% of calories, derived from vegetable oils; referred to below as "Chow" diet). Animals were fasted overnight and blood samples were drawn from the femoral vein after immobilization with ketamine (10 mg/kg body weight). The same animals were then fed a diet enriched in cholesterol (1.7 mg/kcal) and saturated fat (40% of total calories, derived from lard; HCSF diet). After eating this diet for 7 weeks, fasted animals were bled for the HCSF diet sample. All protocols were reviewed and approved by the institutional Animal Care and Use Committee.
Serum was isolated by low-speed centrifugation and was stored at -80°C as individual aliquots in plastic tubing segments.38 This method of storage ensures that each sample is subjected to a single freeze-thaw cycle before analysis and is protected from oxidation and desiccation.
Measurement of Cholesterol Concentration in HDL
Subfractions
HDL-C concentrations were measured
enzymatically39 40 in the serum supernatant after
precipitation of apoB-containing lipoproteins by use of
heparin-Mn2+.41 42 HDL particles
were resolved on the basis of size by use of gradient gel
electrophoresis in nondenaturing gradient gels (PAA 2 to 16,
Pharmacia). Distributions of cholesterol were visualized by
prestaining with Sudan black B,33 43 which has been shown
to be a reliable indicator of lipoprotein cholesterol
concentrations.44 45 46 47 Gels were subjected to densitometry
at 610 nm with a Cliniscan Densitometer (Helena Laboratories). HDL
absorbance profiles were then cut into 3 fractions on the basis of
consistent features of a lyophilized baboon serum standard that
was run on each gel. The fractions (and their approximate size
intervals33 ) were HDL3 (8.2 to 10.2
nm), HDL2 (10.2 to 14.2 nm), and
HDL1 (14.2 to 19.3 nm). Absorbances within each
fraction were summed and expressed as a fraction of total HDL
absorbance and then multiplied by the HDL-C value to obtain
cholesterol concentrations within each HDL subfraction
(detailed description and validation are presented
elsewhere43 ). We have previously reported the
multivariate coefficient of variation for these
measures to be 8.2%.33
Statistical Genetic Analysis
We used the computer package PEDSYS48 for pedigree
and phenotype data management and preparation. Statistical
genetic analyses were conducted using maximum likelihood
methods to compute the likelihoods of genetic models on data from
pedigrees.49
In accordance with established quantitative genetic
theory,50 we partitioned the total phenotypic variance in
the traits (
2P) into
2G, the variance due to the
additive effects of genes, and
2E, the variance due to
nongenetic (or environmental) effects. We estimated heritability
(h2), the proportion of the phenotypic
variance due to the additive effects of genes, for each of the
subfractions as
2G/
2P.
We modeled the multivariate phenotype of an
individual as a linear function of the measurements on the
individual's traits, the means of these traits in the population, and
the covariates and their regression coefficients, plus the additive
genetic values and unmeasured nongenetic deviations.51 52 53 54 55
We further partitioned the phenotypic variance-covariance
matrix into the additive genetic and environmental
variance-covariance matrices, given the relationships (kinship
coefficients) observed in the pedigree. From these 2 matrices, we
estimated the additive genetic correlation,
G, and the environmental correlation,
E, between trait pairs. Respectively, these
correlations are estimates of the additive effects of shared genes (ie,
pleiotropy) and shared unmeasured, nonhereditary (often referred to as
"random environmental") factors on the variance in a trait. Because
the contributions of the genetic and environmental components of the
phenotypic correlation matrix are additive,50 we used
the maximum likelihood estimates of these 2 correlations to obtain the
total phenotypic correlation,
P, between 2
traits as
![]() | (1) |
), heritabilities (h2), and the
effects of sex, age-by-sex, age2-by-sex, nursery
status (a dichotomous trait: baboons reared until weaning in a nursery
were scored as "1" and those reared by mothers, "0"), and
percent Yellow baboon admixture (method of calculation is reported
elsewhere36 ) for all 6 traits, as well as the genetic
and environmental correlations between them. Before analysis,
we performed a loge (ln) transformation on the
HDL-C subfraction data to reduce skewness and to mitigate effects of
scale on parameter estimation. No other prior adjustments
to the data were made. Although the hexavariate model applied in this study is a polygenic one, it is possible, in fact likely, that individual loci contribute some proportion of the shared variation between the phenotypes in the different dietary environments. The maximum likelihood methods used rely on the assumption of multivariate normality as a "working model," but are robust to deviations from multivariate normality in the underlying distribution.57 Consequently, valid maximum likelihood estimates for the parameters of the genetic model can be obtained even if major loci, not modeled in this analysis, are involved.57
We assessed the significance of each of the estimated
parameters (excluding means, µ, and standard deviations,
) by likelihood ratio tests, wherein -2xln likelihood of a
restricted model, in which a parameter value is fixed at 0,
is compared with the similarly calculated value for the more general
hexavariate model, in which all parameter values are
estimated. The likelihood ratio test statistic,
[i] (where i indicates
degrees of freedom), is distributed approximately as a
2 variate with degrees of freedom equal to the
difference in the number of parameters in the 2 models
being compared.58 A hypothesis of pleiotropy is
supported when an additive genetic correlation is found by likelihood
ratio test to be significantly different from zero. Complete pleiotropy
would indicate that the same gene or set of genes was influencing
variation in HDL-C subfraction levels to the same degree in both diets.
As a test for complete pleiotropy, we compared the likelihood of an
unrestricted model in which the genetic correlation is estimated with
that of a restricted model in which it is fixed at 1.0.
Detecting Genotype by Diet Interactions
We have implemented an analytical approach that enables us to
quantify the proportion of the variance in response to these 2 dietary
environments that is attributable to the additive effects of genes. We
consider the 2 dietary regimens as different environments.
Genotype by environment interaction occurs when there is a
significant genetic component to the variance in response to the
environment.59 The additive genetic variance in an HDL-C
subfraction's response is a function of both that subfraction's
additive genetic variance in the 2 diets and the additive genetic
correlation between levels of that subfraction in the 2 diets. An
absence of additive genetic variance in response to the diet implies
that there is no additive polygenotype by diet interaction.
This occurs when the proportions of the variances due to the additive
effects of genes are equal in both diets (when
2G1=
2G2)
and when the proportion of the correlation between 1 subfraction in the
2 diets that is due to the additive effects of shared genes is complete
(ie, positive pleiotropy,
G=1).59 These 2 conditions
serve as null hypotheses. Although the rejection of either is
indicative of polygenotype by diet interaction, the more
salient of the two is the test of equal genetic variances for the same
subfraction in 2 diets.
To test the first of these hypotheses for each of the i
subfractions, we estimated the additive genetic variance of the
response to the 2 diets as
![]() | (2) |
Pi is the maximum likelihood
estimate of the 2 residual phenotypic standard deviations (one from
each of the i=2 environments), and
h2 is the heritability estimate. First-order Taylor series approximations of the standard errors of these estimates were obtained from the variance-covariance matrix of the genetic correlations with respect to the genetic variances. A Wald test with 1 degree of freedom60 was used to determine the significance of the genetic variance of the response for each HDL-C subfraction to the 2 diets.
| Results |
|---|
|
|
|---|
|
Maximum likelihood estimates of h2 as
well as of the phenotypic means, standard deviations, covariate
effects, and their standard errors are found in Table 2
(note that because the 95% confidence
intervals about the maximum likelihood parameter estimates
are asymmetrical, the common practice of adding ±2 times the standard
error to the estimate will not reliably indicate significance).
Likelihood ratio tests disclosed significant additive genetic effects,
ie, significant h2 estimates, on all 3
HDL-C subfractions measured in both diets. Significant sex effects were
found only for HDL2-C measured on the HCSF diet.
For both sexes, age contributed significantly to variation in
HDL1-C and HDL3-C levels on
the Chow diet, but on the HCSF diet, age influenced variation in
HDL1-C and HDL2-C only in
females and in HDL3-C only in males. Nursery and
percent P h cynocephalus admixture (ßsubspecies) effects
were significant only for HDL3-C measured on the
HCSF diet.
|
The hypothesis of different means in the 2 dietary environments for
each subfraction was also addressed. Likelihood ratio tests rejected
the hypothesis
µCHOW=µHCSF for
HDL1-C
(
2[1]=63.48,
P<0.000001) and HDL2-C
(
2[1]=224.47, P<<0.000001)
but not for HDL3-C
(
2[1]=0.04,
P=0.81).
Table 3
presents maximum likelihood
estimates of the additive genetic and environmental correlations and
their standard errors plus the phenotypic correlations calculated using
equation 1
. In data from animals on the Chow diet, we observed
significant genetic correlations between all 3 subfractions
[P(
G=0)<0.001] and could not
reject complete pleiotropy
[P(||
G||=1.0)>0.1] between
HDL1-C and HDL3-C
(
G=-0.82). Within the Chow dietary
environment, shared genes account for 38% to 67% of the genetic
variance in the 3 subfractions. In data obtained from animals after the
HCSF dietary challenge, only the genetic correlation between
HDL1-C and HDL3-C
(
G=-0.62) was significant
(P<0.01). Within the HCSF dietary environment, shared genes
account for about 38% of the genetic variance in these 2 subfractions.
Likelihood ratio tests revealed significant additive genetic
correlations, indicative of pleiotropy, between the same HDL-C
subfractions measured in both the Chow diet and HCSF diets. Up to 100%
of the genetic variance in levels of HDL1-C in
the 2 dietary environments is attributable to the shared additive
effects of the same genes. The same is true for the
HDL3-C subfraction. For
HDL2-C, more than 72% of the genetic variance in
levels of this subfraction measured in the 2 diets is because of the
additive effects of shared genes.
|
The product of the squared genetic correlation and the heritability
for 1 of the 2 correlated phenotypes (ie,
2I,jxh2
yields an estimate of the proportion of the residual (ie, after
partitioning out the effects of measured covariates) phenotypic
variance for that phenotype that is attributable to the effects
of shared genes (Table 4
). Shared genes
account for a greater proportion of the residual phenotypic variance in
all subfractions measured in the Chow diet than in those measured in
the HCSF environment. In the Chow diet, genes shared by
HDL1-C and the other 2 subfractions account for a
greater proportion of both their genetic and residual phenotypic
variances than do genes shared by HDL2-C and
HDL3-C. Within the HCSF dietary environment, this
relationship does not obtain. Only genes shared by
HDL1-C and HDL3-C account
for more than 5% of the residual phenotypic variance in subfraction
pairs measured in animals on the HCSF diet (18.5% and 14.3%,
respectively).
|
Because maximum likelihood estimates of genetic correlations between the same subfraction measured on the 2 diets were either 1.0 or, in the case of HDL2-C, not significantly different from 1.0, the proportions of the residual phenotypic variance attributable to shared genes approximated the diet-specific heritability estimates of the subfractions. Compared with the Chow diet estimates, the proportion of the residual phenotypic variance due to shared gene effects on the HCSF diet was increased for HDL1-C, but reduced by more than half for HDL2-C and only slightly for HDL3-C.
The environmental correlations between the 3 HDL-C subfractions exhibit
very similar patterns in the 2 diets (Table 3
). On both Chow and
HCSF diets, the correlations between HDL1-C and
HDL3-C are of greatest magnitude. Approximately
25% of the variance due to unmeasured, nongenetic factors in these 2
subfractions is accounted for by factors that are shared in both the
Chow and HCSF environments. This proportion does not exceed 3.9% for
any of the other subfraction pairs within each diet. There is less
difference between the environmental correlations obtained when
comparing each of the same subfractions across the 2 diets. For
example, at
E=0.30, the environmental
correlation between the 2 HDL2-C measures is
about 50% higher than those for the other 2 subfractions. On average,
shared unmeasured, nongenetic factors account for slightly more than
3% (HDL3-C) to 9%
(HDL2-C) of the environmental variance in
subfraction concentration between diets.
The product of the squared environmental correlation
(
2E) and the quantity
1-h2 provides an estimate of the
proportion of the residual phenotypic variance for a phenotype
that is attributable to the shared effects of unmeasured nongenetic
factors (Table 5
). Shared unmeasured,
nongenetic effects account for more than 10% of the residual
phenotypic variance only for HDL1-C and
HDL3-C levels measured within each of the 2
diets. Unmeasured, nongenetic effects shared by the same fraction
assayed in 2 different diets account for no more than 7.2% of the
residual phenotypic variance.
|
Tests of the hypothesis
2G1=
2G2
reveal significant differences between the additive genetic variances
of the 2 dietary environments for HDL1-C (0.396
versus 0.539 on Chow and HCSF diets, respectively;
2=30.0, P<0.000001) and
HDL2-C (0.205 versus 0.122;
2=31.4, P<0.000001), but not for
the HDL3-C subfraction (0.214 versus 0.209;
2=0.05, P=0.92). In the cases of
HDL1-C and HDL2-C, this
indicates that the additive genetic variance of the response to the
dietary environments was significantly different from
zero.59 When compared with that estimated for the
Chow diet, the additive genetic variance in the HCSF diet was increased
by 36% for HDL1-C and decreased by 40.5% for
HDL2-C, remaining essentially unchanged for
HDL3-C.
| Discussion |
|---|
|
|
|---|
Using a maximum likelihood-based hexavariate quantitative genetic analysis strategy applied to data from 942 pedigreed captive baboons, we have assessed the relative contributions of genes, shared genes, and shared nongenetic factors to normal phenotypic variation in serum levels of 3 HDL-C subfractions measured in 2 dietary environments. Further, we have tested these data for evidence of interaction between the 2 diets and the detected genes. We interpret the results of our analyses to indicate that variation in dietary cholesterol and fat intake influences quantitative variation in serum concentrations of the 3 HDL-C subfractions through effects on the expression of genes responsible for normal variation in levels of these 3 subfractions. In addition to demonstrating the existence of these genotype by diet interactions, the results of our analyses also provide indications of their magnitude and nature.
Our observations of significant increases in mean levels of
HDL1-C and HDL2-C, but not
of HDL3-C, in response to the HCSF diet are
consistent with those reported by others, including
observations of increased HDL2b and no change in
HDL3 in response to dietary supplementation with
n-3 fatty acids in humans61 ; an association between
increased formation of HDL particles and n-6
-linolenic
acidenriched evening primrose oil in rabbits62 ; and
increased HDL levels mediated by the effects of dietary fat on the
fractional catabolic rate of HDL cholesterol ester in the
human apoA1 mouse.63 We note, however, that significant
changes in phenotypic means are not necessary preconditions for the
subsequent detection of a genotype by diet interaction. In
fact, genotype by diet interaction can occur in the absence of
significant changes in phenotype means. This would be the case,
for example, if responses of specific genotypes were in
opposite directions with respect to the original mean and their changes
effectively canceled the effect of one another on the population
mean.
As noted above, the influence of genes on quantitative variation in levels of HDL-C and its subfractions is well accepted. The mean of the 6 heritability estimates in this study, 0.32, is within the range of heritability estimates reported for total HDL-C levels in numerous human twin and family studies, between 0.16 and 0.79 (reviewed previously55 ).
Observation of pleiotropy between the different HDL-C subfraction levels within the basal Chow diet is not entirely unexpected. A few studies have reported observations consistent with pleiotropic relationships between the HDL subclasses. One study64 of data from 116 human probands undergoing coronary arteriography at an early age, plus 676 relatives, detected possible pleiotropic effects of a locus, which also accounts for 33% of the variation in HDL3-C levels, on total HDL concentration and size. A multivariate segregation analysis of data from the Donner Laboratory Family Study detected evidence for a major locus for apoA1 serum levels that exerts pleiotropic effects on the relative distribution of HDL subfractions.65 Also, a study of 717 individuals from 26 families in the San Antonio Family Heart Study66 reported significant shared additive genetic effects on the distributional patterns of apoA1 among HDL subclasses. However, detecting significant pleiotropic interactions between the 3 subfractions and determining that the magnitudes of these interactions are diet-specific are novel outcomes of this study. In this nonhuman primate model for dietary and genotypic interactions with atherosclerosis risk factors, shared genes account for a greater proportion of the genetic variance in the 3 subfractions under a low cholesterol, low fat diet than under an HCSF diet. On the Chow diet, much of the genetic variance and a moderate amount of the residual phenotypic variance in the 3 different subfractions is attributable to the effects of shared genes. In contrast, on the HCSF diet, only HDL1-C and HDL3-C exhibit significant shared genetic effects. We interpret these differences as evidence for HCSF diet-induced alterations of the pleiotropic relationships among the 3 subfractions.
Comparison of the shared genetic effects on each of the 3 HDL-C subfractions measured in 2 different dietary environments provides additional information regarding this possible genotype by diet effect. Between dietary environments, shared genes account for nearly all of the genetic variance and moderate amounts of the phenotypic variance in each of the 3 subfractions. That is, for the most part, the detected significant changes in mean levels of 2 of the HDL-C subfractions are not caused by the additive effects of different genes in different dietary environments. Rather, we suggest that these differences are attributable to changes in expression of the shared genes in response to the HCSF diet.
The significant genetic contribution to the response to diet for HDL1-C and HDL2-C, the 2 subfractions that also exhibit significantly different mean levels under the 2 diets, provides further support for this suggestion. Specifically, the high cholesterol, high saturated fat levels of the HCSF diet are associated with a change in gene expression such that the genetic variance for the HDL1-C subfraction is increased whereas that for the HDL2-C subfraction is decreased. We conclude that some genes within the suite of genes influencing phenotypic variation in total HDL-C may exert dissimilar effects on different HDL subfractions in response to diet.
Shared, unmeasured environmental factors account for only moderate proportions of the residual environmental and phenotypic variances in HDL1-C and HDL3-C within dietary environments, and small to negligible proportions between dietary environments. Because these "environmental" correlations reflect shared effects of unmeasured, noninherited factors, it is unlikely that our inferences regarding additive genetic pleiotropy are biased upward or would be diminished by the subsequent elucidation, and inclusion in our models, of one or more of these factors. It is more likely that such additions to our analyses would only serve to increase the signal to noise ratio of the detected shared additive genetic effects.
We expect to follow up on these observations to obtain additional indications of the genetic, environmental, and metabolic contributions to the changes in the pleiotropic relationships among the 3 subfractions under the HCSF diet. A study in which many of these same animals have been challenged with a third diet that is low in cholesterol but high in saturated fats has begun to yield insights regarding the differential effects of cholesterol and saturated fat on the genes influencing lipemic response in LDL-C levels.67 Additionally, we have shown elsewhere68 69 70 that knowledge of both the pleiotropic interactions and shared effects of unmeasured nongenetic factors on pairs of phenotypes can be exploited to detect and localize specific genes influencing quantitative variation in those traits. Using the pleiotropy detected between HDL-C subfractions in these pedigreed baboons on 2 diets, we are initiating multivariate, multipoint variance component whole genome linkage screens71 to identify chromosomal regions harboring genes influencing lipemic response to a high cholesterol, high fat diet.
| Acknowledgments |
|---|
Received February 4, 1997; accepted October 29, 1998.
| References |
|---|
|
|
|---|
2.
Cheung MC, Albers JJ. Characterization of
lipoprotein particles isolated by immunoaffinity
chromatography: particles containing A-I and A-II
particles and particles containing A-I but no A-II. J Biol
Chem. 1984;259:1220112209.
3. Miller GJ, Miller NE. High-density-lipoprotein concentration and development of ischaemic heart disease. Lancet. 1975;1:1619.[Medline] [Order article via Infotrieve]
4. Rhoads GG, Gulbrandsen CL, Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaiian Japanese men. New Engl J Med. 1976;294:293298.[Abstract]
5. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoproteins as a protective factor against coronary heart disease. Am J Med. 1977;62:707714.[Medline] [Order article via Infotrieve]
6. Wiklund O, Wilhelmsen L, Elmsfeldt D, Wedel H, Valek J, Gustafsen A. Alpha-lipoprotein cholesterol concentration in relation to subsequent myocardial infarction in hypercholesterolemic men. Atherosclerosis. 1980;37:4753.[Medline] [Order article via Infotrieve]
7.
Manninen V, Elo MO, Frick MH, Haapa K, Heinonen OP,
Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Maenpaa H,
Malkonen M, Mantarri M, Norola S, Pasternack A, Pikkarainen J, Romo M,
Sjoblom T, Nikkila EA. Lipid alterations and decline in the incidence
of coronary heart disease in the Helsinki Heart Study.
JAMA. 1988;260:641651.
8. Rifai N, Chapman JF, Siverman LM, Gwynnes JT. Review of serum lipids and apolipoproteins in risk-assessment of coronary heart disease. Ann Clin Lab Sci. 1988;18:429439.[Abstract]
9.
Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD,
Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA. High
density lipoprotein cholesterol and
cardiovascular disease: four prospective American
studies. Circulation. 1989;79:815.
10. Silverman DI, Ginsberg GS, Pasternak RC. High-density lipoprotein subfractions. Am J Med. 1993;94:636645.[Medline] [Order article via Infotrieve]
11. Atger V, Giral P, Simon A, Cambillau M, Levenson J, Gariepy J, Megnen JL, Moatti N, PCVMETRA Group. High-density lipoprotein subfractions as markers of early atherosclerosis. Am J Cardiol. 1995;75:127131.[Medline] [Order article via Infotrieve]
12.
Rainwater DL, Ludwig MJ, Haffner SM, VandeBerg JL.
Lipid and lipoprotein factors associated with variation in Lp(a)
density. Arterioscler Thromb Vasc Biol. 1995;15:313319.
13.
Singh ATK, Rainwater DL, Kammerer CM, Sharp RM,
Poushesh M, Shelledy WR, VandeBerg JL. Dietary and genetic effects on
LDL sizes measures in baboons. Arterioscler Thromb Vasc
Biol. 1996;16:14481453.
14.
Campos H, Roederer GO, Lussier-Cacan S, Davignon J,
Krauss RM. Predominance of large LDL and reduced
HDL2 cholesterol in normolipidemic
men with coronary artery disease. Arterioscler Thromb
Vasc Biol. 1995;15:10431048.
15.
Halle M, Berg A, Keul J, Baumstark MW. Association
between serum fibrinogen concentrations and HDL and LDL subfraction
phenotypes in healthy men. Arterioscler Thromb Vasc
Biol. 1996;16:144148.
16. Syvänne M, Ahola M, Lahdenperä S, Kahri J, Kuusi T, Virtanen KS, Taskinen M-R. High-density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res. 1995;36:573582.[Abstract]
17.
Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AM.
Inverse relationship between blood levels of high density lipoprotein
subfraction 2 and magnitude of postprandial lipemia. Proc Natl
Acad Sci U S A. 1983;80:14491453.
18.
Calabresi L, Cassinotti M, Gianfranceschi G, Safa O,
Murakami T, Sirtori CR, Franceschini G. Increased postprandial lipemia
in Apo A-IMilano carriers. Arterioscler Thromb Vasc Biol. 1993;13:521528.
19.
Clifton PM, Kestin M, Abbey M, Drysdale M, Nestel PJ.
Relationship between sensitivity to dietary fat and dietary
cholesterol.
Arteriosclerosis. 1990;10:394401.
20.
Katan MB, Beynen AC. Characteristics of human hypo- and
hyperresponders to dietary cholesterol. Am J
Epidemiol. 1987;125:387399.
21. Fisher WR. Heterogeneity of plasma low density lipoprotein manifestations of the physiologic phenomenon in man. Metabolism. 1983;32:283291.[Medline] [Order article via Infotrieve]
22. Despres JP, Poehlman ET, Tremblay A, Lupien PJ, Moojani S, Nadeau A, Perusse L, Bouchard C. Genotype-influenced changes in serum HDL cholesterol after short-term overfeeding in man: association with plasma insulin and triglyceride levels. Metabolism. 1987;36:363368.[Medline] [Order article via Infotrieve]
23.
Mata P, Ordovas JM, Lopez-Miranda J, Lichtenstein AH,
Clevidence B, Judd JT, Schaefer EJ. ApoA-IV phenotype affects
diet-induced plasma LDL cholesterol lowering.
Arterioscler Thromb. 1994;14:884891.
24. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, Quinet E, Tall AR, Marcel YL, McPherson R. Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol overfeeding in men: relationship to apolipoprotein E genotype. J Lipid Res. 1993;34:437446.[Abstract]
25. McGill HC Jr, Kushwaha RS. Individuality of lipemic responses to diet. Can J Cardiol. 1995;11(suppl G):15G27G.
26. Rainwater DL, VandeBerg JL. Dramatic differences in lipoprotein composition among gray short-tailed opossums (Monodelphis domestica) fed a high cholesterol saturated fat diet. Biochim Biophys Acta. 1992;1126:159166.[Medline] [Order article via Infotrieve]
27.
Paigen B, Mitchell D, Reue K, Morrow A, Lusis AJ,
LeBoeuf RC. Ath-1, a gene determining
atherosclerosis susceptibility and high density
lipoprotein levels in mice. Proc Natl Acad Sci U S A. 1987;84:37633767.
28. Eggen DA. Cholesterol metabolism in rhesus monkey, squirrel monkey, and baboon. J Lipid Res. 1974;15:139145.[Abstract]
29. McGill HC Jr, McMahan CA, Kruski AW, Kelley JL, Mott GE. Responses of serum lipoproteins to dietary cholesterol and type of fat in the baboon. Arteriosclerosis. 1981;6:337344.
30.
Flow BL, Cartwright TC, Kuehl TJ, Mott GE, Kraemer DC,
Kruski AW, Williams JD, McGill HC Jr. Genetic effects on serum
cholesterol concentrations in baboons. J
Hered. 1981;72:97103.
31. Kammerer CM, Mott GE, Carey KD, McGill HC Jr. Effects of selection for serum cholesterol concentrations on serum lipid concentrations and body weight in baboons. Am J Med Genet. 1984;19:333345.[Medline] [Order article via Infotrieve]
32. MacCluer JW, Kammerer CM, Blangero J, Dyke B, Mott GE, VandeBerg JL, McGill HC Jr. Pedigree analysis of HDL cholesterol concentration in baboons on two diets. Am J Hum Genet. 1988;43:401413.[Medline] [Order article via Infotrieve]
33.
Rainwater DL, Blangero J, Hixson JE, Birnbaum S, Mott
GE, VandeBerg JL. A DNA polymorphism for LCAT is associated with
altered LCAT activity high density lipoprotein size distributions.
Arterioscler Thromb. 1992;12:682690.
34. Blangero J, MacCluer JW, Kammerer CM, Dyer TD, Mott GE, McGill HC Jr. Genetic analysis of apolipoprotein A-I in two dietary environments. Am J Hum Genet. 1990;47:414428.[Medline] [Order article via Infotrieve]
35. VandeBerg JL, Cheng M-L. The genetics of baboons in biomedical research. In: Else JG, Lee PV, eds. Primate Evolution. Cambridge: Cambridge University Press; 1986:317321.
36. Williams-Blangero S, VandeBerg JL, Blangero J, Konigsberg L, Dyke B. Genetic differentiation between baboon subspecies: relevance for biomedical research. Am J Primatol. 1990;20:6781.
37.
Boyce AJ. Computation of inbreeding and kinship
coefficients on extended pedigrees. J Hered. 1983;74:400404.
38. Cheng M-L, Woodford SC, Hilburn JL, VandeBerg JL. A novel system for storage of sera frozen in small aliquots. Biochem Biophys Methods. 1986;13:4751.[Medline] [Order article via Infotrieve]
39. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470475.[Abstract]
40. Witte DL, Barrett DA II, Wycoff DA. Evaluation of an enzymatic procedure for determination of serum cholesterol with the Abbott ABA-100. Clin Chem. 1974;20:12821286.[Abstract]
41.
Burstein M, Samaille J. Sur un dosage rapide du
cholesterol lie aux
-et aux ß-lipoproteines du
serum. Clin Chim Acta. 1960;5:609.[Medline]
[Order article via Infotrieve]
42. Lipid Research Clinics Program. Manual of Laboratory Operations. Volume 1: Lipid and Lipoprotein Analysis. Washington, DC: US Dept of Health, Education, and Welfare; 1974. Publication NIH 75-628:5658.
43. Cheng M-L, Kammerer CM, Lowe WF, Dyke B, VandeBerg JL. Method for quantitating cholesterol in subfractions of serum lipoproteins separated by gradient gel electrophoresis. J Biochem Genet. 1988;13:657681.
44. Burton PM, Chiou YM. Isolation, characterization and quantification of apolipoproteins A-I and B of the golden Syrian hamster (Mesocricetus auratus) and modification of their levels by dietary cholesterol. Comp Biochem Physiol B. 1989;92B:667673.
45. Le Goff D, Pastier D, Hannan Y, Petit E, Ayrault-Jarrier M, Nouvelot A. Lipid and apolipoprotein distribution as a function of density in equine plasma lipoprotein. Comp Biochem Physiol B. 1989;93B:371377.
46.
Callais F, Roche D, Andreux JP. Value of
polyacrylamide gradient gel electrophoresis of lipoproteins for
determining HDL cholesterol. Clin Chem. 1987;33:1266.
47. Gambert P, Farnier M, Bouzerand C, Athias A, Lallemant C. Direct quantitation of serum high density lipoprotein subfractions separated by gradient gel electrophoresis. Clin Chim Acta. 1988;172:183190.[Medline] [Order article via Infotrieve]
48. Dyke B. PEDSYS. A Pedigree Data Management System. Population Genetics Laboratory, Southwest Foundation for Biomedical Research, San Antonio. 1992.
49. Hasstedt SJ. Pedigree Analysis Package, v 3.0. Department of Genetics, University of Utah, 1989.
50. Falconer DS. Introduction to Quantitative Genetics. 4th ed. New York: Longman Scientific and Technical; 1996.
51.
Boehnke M, Moll PP, Kottke BA, Weidman WH. Partitioning
the variability of fasting glucose levels in pedigrees. Am J
Epidemiol. 1987;125:679689.
52. Hopper JL, Mathews JD. Extensions to multivariate normal models for pedigree analysis. Ann Hum Genet. 1982;46:373383.
53. Lange K, Boehnke M. Extensions to pedigree analysis IV: covariance components models for multivariate traits. Am J Med Genet. 1983;14:513524.[Medline] [Order article via Infotrieve]
54. Williams-Blangero S, Blangero J. Quantitative genetic analysis of skin reflectance: a multivariate approach. Hum Biol. 1992;64:3549.[Medline] [Order article via Infotrieve]
55.
Mahaney MC, Blangero J, Comuzzie AG, VandeBerg JL,
Stern MP, MacCluer JW. Plasma HDL cholesterol,
triglycerides, and adiposity: a quantitative genetic test
of the conjoint trait hypothesis in the San Antonio Family Heart Study.
Circulation. 1995;92:32403248.
56. Blangero J, Konigsberg LW. Multivariate segregation analysis using the mixed model. Genet Epidemiol. 1991;8:299316.[Medline] [Order article via Infotrieve]
57. Beaty TH, Self SG, Liang KY, Connolly MA, Chase GA, Kwiterovich PO. Use of robust variance components models to analyse triglyceride data in families. Ann Hum Genet. 1985;49:315328.[Medline] [Order article via Infotrieve]
58. Edwards AWF. Likelihood. Expanded Edition. Baltimore: Johns Hopkins University Press; 1992.
59. Blangero J. Statistical genetic approaches to human adaptability. Hum Biol. 1993;65:941966.[Medline] [Order article via Infotrieve]
60. Stuart A, Ord JK, eds. Kendall's Advanced Theory of Statistics. Vol 2. 5th ed. New York: Oxford University Press; 1991.
61. Baumstark MW, Frey I, Berg A, Keul J. Influence of n-3 fatty acids from fish oils on concentration of high- and low-density lipoprotein subfractions and their lipid and apolipoprotein composition. Clin Biochem. 1992;25:338340.[Medline] [Order article via Infotrieve]
62. Fragoso YD, Skinner ER. The effect of gammalinolenic acid on the subfractions of plasma high density lipoprotein of the rabbit. Biochem Pharmacol. 1992;44:10851090.[Medline] [Order article via Infotrieve]
63. Hayek T, Ito Y, Azrolan N, Verdery RB, Aalto-Setälä K, Walsh A, Breslow JL. Dietary fat increases high density lipoprotein (HDL) levels both by increasing the transport rates and decreasing the fractional catabolic rates of HDL cholesterol ester and apolipoprotein (Apo) A-I. J Clin Invest. 1993;91:16651671.
64.
Coresh J, Beaty TH, Prenger VL, Xu J, Kwiterovitch PO
Jr. Segregation analysis of HDL3-C levels
in families of patients undergoing coronary arteriography at an
early age. Arterioscler Thromb Vasc Biol. 1995;15:13071313.
65. Blangero J, Williams-Blangero S, Mahaney MC. Multivariate genetic analysis of Apo AI concentration and HDL subfractions: evidence for major locus pleiotropy. Genet Epidemiol. 1993;10:617622.[Medline] [Order article via Infotrieve]
66. Rainwater DL, Blangero J, Moore PH Jr, Shelledy WR, Dyer TD. Genetic control of apolipoprotein A-I distribution among HDL subclasses. Atherosclerosis. 1995;118:307317.[Medline] [Order article via Infotrieve]
67.
Rainwater DL, Kammerer CM, Hixson JE, Carey KD, Rice
KS, Dyke B, VandeBerg JF, Slifer SH, Atwood LD, McGill HC Jr, VandeBerg
JL. Two major loci control variation in ß-lipoprotein
cholesterol and response to dietary fat and
cholesterol in baboons. Arterioscler Thromb Vasc
Biol. 1998;18:10611068.
68.
Mahaney MC, Blangero J, Rainwater DL, Comuzzie AG,
VandeBerg JL, Stern MP, MacCluer JW, Hixson JE. A major locus
influencing plasma high-density lipoprotein cholesterol
levels in the San Antonio Family Heart Study: segregation and linkage
analyses. Arterioscler Thromb Vasc Biol. 1995;15:17301739.
69. Mahaney MC, Jaquish CE, Comuzzie AG. Statistical genetics of normal variation in family data for oligogenic diseases. Genet Epidemiol. 1995;12:783787.[Medline] [Order article via Infotrieve]
70. Comuzzie AG, Mahaney MC, Almast L, Dyer TD, Blangero J. Exploiting pleiotropy to map genes for oligogenic phenotypes using extended pedigree data. Genet Epidemiol. 1997;14:975980.[Medline] [Order article via Infotrieve]
71. Almasy L, Blangero J. Multipoint QTL analysis in pedigrees. Am J Hum Genet. 1998;62:11981211.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
D. L. Rainwater, L. A. Cox, J. Rogers, J. L. VandeBerg, and M. C. Mahaney Localization of multiple pleiotropic genes for lipoprotein metabolism in baboons J. Lipid Res., July 1, 2009; 50(7): 1420 - 1428. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M Ordovas Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1509S - 1517S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Cox, S. Birnbaum, M. C. Mahaney, D. L. Rainwater, J. T. Williams, and J. L. VandeBerg Identification of Promoter Variants in Baboon Endothelial Lipase That Regulate High-Density Lipoprotein Cholesterol Levels Circulation, September 4, 2007; 116(10): 1185 - 1195. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Rainwater, M. C. Mahaney, X. L. Wang, J. Rogers, L. A. Cox, and J. L. VandeBerg Determinants of variation in serum paraoxonase enzyme activity in baboons J. Lipid Res., July 1, 2005; 46(7): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Demmers, P. J. H. Jones, Y. Wang, S. Krug, V. Creutzinger, and J. E. Heubi Effects of Early Cholesterol Intake on Cholesterol Biosynthesis and Plasma Lipids Among Infants Until 18 Months of Age Pediatrics, June 1, 2005; 115(6): 1594 - 1601. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |